Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Colao

Showing results (201-210 of 391) with videos related to

Pageof 40
Sort By:
Journal of Endocrinological Investigation|November 3, 2014
Erratum to: GLP-1: benefits beyond pancreasG Muscogiuri, A Cignarelli, F Giorgino, et al.
Journal of Endocrinological Investigation|July 1, 1997
Failure of long-term therapy with sodium valproate in Cushing's diseaseA Colao, R Pivonello, F S Tripodi, et al.
Journal of Endocrinological Investigation|April 29, 1999
The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomasA Colao, S Lastoria, D Ferone, et al.
Journal of Endocrinological Investigation|April 21, 2001
Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three casesP Cappabianca, S Lodrini, G Felisati, et al.
Clinical Endocrinology|April 25, 2001
In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphyD Ferone, R Pivonello, S Lastoria, et al.
European Journal of Nuclear Medicine|April 1, 1996
Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: assessment with radionuclide angiographyA Cuocolo, E Nicolai, A Colao, et al.
Hormone Research|January 1, 1995
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomasA Colao, B Merola, F Sarnacchiaro, et al.
Clinical Endocrinology|July 17, 1998
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's diseaseC Di Somma, A Colao, R Pivonello, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenomaE Arvat, R Giordano, J Ramunni, et al.
The American Journal of Physiology|August 1, 1994
Impaired cardiac performance in GH-deficient adults and its improvement after GH replacementA Cittadini, A Cuocolo, B Merola, et al.
Pageof 40

Showing results (201-210 of 391) with videos related to

Sort By:
Pageof 40
Journal of Endocrinological Investigation|November 3, 2014
Erratum to: GLP-1: benefits beyond pancreasG Muscogiuri, A Cignarelli, F Giorgino, et al.
Journal of Endocrinological Investigation|July 1, 1997
Failure of long-term therapy with sodium valproate in Cushing's diseaseA Colao, R Pivonello, F S Tripodi, et al.
Journal of Endocrinological Investigation|April 29, 1999
The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomasA Colao, S Lastoria, D Ferone, et al.
Journal of Endocrinological Investigation|April 21, 2001
Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three casesP Cappabianca, S Lodrini, G Felisati, et al.
Clinical Endocrinology|April 25, 2001
In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphyD Ferone, R Pivonello, S Lastoria, et al.
European Journal of Nuclear Medicine|April 1, 1996
Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: assessment with radionuclide angiographyA Cuocolo, E Nicolai, A Colao, et al.
Hormone Research|January 1, 1995
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomasA Colao, B Merola, F Sarnacchiaro, et al.
Clinical Endocrinology|July 17, 1998
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's diseaseC Di Somma, A Colao, R Pivonello, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenomaE Arvat, R Giordano, J Ramunni, et al.
The American Journal of Physiology|August 1, 1994
Impaired cardiac performance in GH-deficient adults and its improvement after GH replacementA Cittadini, A Cuocolo, B Merola, et al.
Pageof 40